Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas

Frontiers of Medicine in China

Volumn 4, Issue 4, 2010, Pages 399-411

  Chen, Lei ^a   Hu, Liang ^a   Li, Liang ^a   Liu, Yuan ^a   Tu, Qian Qian ^a   Chang, Yan Xin ^a   Yan, He Xin ^a   Wu, Meng Chao ^a   Wang, Hong Yang ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

catenin; cell adhesion; E cadherin; hepatitis B virus X protein; hepatocellular carcinoma; transcriptional activation

Indexed keywords

BETA CATENIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; HEPATITIS B VIRUS X PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL JUNCTION; CELL STRAIN HEPG2; DOWN REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NORTHERN BLOTTING; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIROLOGY; WESTERN BLOTTING;

ADHERENS JUNCTIONS; BETA CATENIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 78650710281     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-010-0170-y     Document Type: Article

References (43)

1. Schafer D F, Sorrell M F. Hepatocellular carcinoma. Lancet, 1999, 353(9160): 1253-1257.
2. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer, 1997, 18(1): 59-65.
3. Feitelson M A, Duan L X. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol, 1997, 150(4): 1141-1157.
4. Su Q, Schröder C H, Hofmann W J, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology, 1998, 27(4): 1109-1120.
5. Kim C M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 1991, 351(6324): 317-320.
6. Slagle B L, Lee T H, Medina D, Finegold M J, Butel J S. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog, 1996, 15(4): 261-269.
7. Terradillos O, Billet O, Renard C A, Levy R, Molina T, Briand P, Buendia M A. The hepatitis B virus X gene potentiates c-mycinduced liver oncogenesis in transgenic mice. Oncogene, 1997, 14(4): 395-404.
8. Benn J, Schneider R J. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A, 1994, 91(22): 10350-10354.
9. Natoli G, Avantaggiati M L, Chirillo P, Puri P L, Ianni A, Balsano C, Levrero M. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene, 1994, 9(10): 2837-2843.
10. Su F, Schneider R J. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol, 1996, 70(7): 4558-4566.
11. Benn J, Su F, Doria M, Schneider R J. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol, 1996, 70(8): 4978-4985.
12. Mahé Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem, 1991, 266(21): 13759-13763.
13. Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem, 1998, 273(50): 33347-33353.
14. Lee T H, Elledge S J, Butel J S. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol, 1995, 69(2): 1107-1114.
15. Ueda H, Ullrich S J, Gangemi J D, Kappel C A, Ngo L, Feitelson M A, Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet, 1995, 9(1): 41-47.
16. Tlsty T D. Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr Opin Cell Biol, 1998, 10(5): 647-653.
17. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet, 1993, 9(9): 317-321.
18. Kozyraki R, Scoazec J Y, Flejou J F, D'Errico A, Bedossa P, Terris B, Fiorentino M, Bringuier A F, Grigioni W F, Feldmann G. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology, 1996, 110(4): 1137-1149.
19. Wei Y, van Nhieu J T, Prigent S, Srivatanakul P, Tiollais P, Buendia M A. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology, 2002, 36(3): 692-701.
20. Peifer M. β-catenin as oncogene: the smoking gun. Science, 1997, 275(5307): 1752-1753.
21. Moon R T, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science, 2002, 296(5573): 1644-1646.
22. He T C, Sparks A B, Rago C, Hermeking H, Zawel L, da Costa L T, Morin P J, Vogelstein B, Kinzler K W. Identification of c-MYC as a target of the APC pathway. Science, 1998, 281(5382): 1509-1512.
23. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398(6726): 422-426.
24. Liu C, Li Y, Semenov M, Han C, Baeg G H, Tan Y, Zhang Z, Lin X, He X. Control of β-catenin phosphorylation/degradation by a dualkinase mechanism. Cell, 2002, 108(6): 837-847.
25. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell, 2000, 103(2): 311-320.
26. de La Coste A, Romagnolo B, Billuart P, Renard C A, Buendia M A, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A, 1998, 95(15): 8847-8851.
27. Samowitz W S, Powers M D, Spirio L N, Nollet F, van Roy F, Slattery M L. β-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res, 1999, 59(7): 1442-1444.
28. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology, 2001, 120(7): 1763-1773.
29. Hsu H C, Jeng YM, Mao T L, Chu J S, Lai P L, Peng S Y. β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol, 2000, 157(3): 763-770.
30. Huang H, Fujii H, Sankila A, Mahler-Araujo B M, Matsuda M, Cathomas G, Ohgaki H. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol, 1999, 155(6): 1795-1801.
31. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene. Cancer Res, 1999, 59(2): 269-273.
32. Lian Z, Liu J, Pan J, Satiroglu Tufan N L, Zhu M, Arbuthnot P, Kew M, Clayton M M, Feitelson M A. A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival. Hepatology, 2001, 34(1): 146-157.
33. Lian Z, Pan J, Liu J, Zhang S, Zhu M, Arbuthnot P, Kew M, Feitelson M A. The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene, 1999, 18(9): 1677-1687.
34. Yan H X, He Y Q, Dong H, Zhang P, Zeng J Z, Cao H F, Wu M C, Wang H Y. Physical and functional interaction between receptorlike protein tyrosine phosphatase PCP-2 and β-catenin. Biochemistry, 2002, 41(52): 15854-15860.
35. Andrews N C, Faller D V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res, 1991, 19(9): 2499-2506.
36. Wang H, Lian Z, Lerch M M, Chen Z, Xie W, Ullrich A. Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene, 1996, 12(12): 2555-2562.
37. Carruba G, Cervello M, Miceli M D, Farruggio R, Notarbartolo M, Virruso L, Giannitrapani L, Gambino R, Montalto G, Castagnetta L. Truncated form of β-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. Ann N Y Acad Sci, 1999, 886: 212-216.
38. Su Q, Schröder C H, Hofmann W J, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology, 1998, 27(4): 1109-1120.
39. Wang W L, London W T, Feitelson M A. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res, 1991, 51(18): 4971-4977.
40. Huber A H, Stewart D B, Laurents D V, Nelson W J, Weis W I. The cadherin cytoplasmic domain is unstructured in the absence of β-catenin. A possible mechanism for regulating cadherin turnover. J Biol Chem, 2001, 276(15): 12301-12309.
41. Polakis P. The oncogenic activation of β-catenin. Curr Opin Genet Dev, 1999, 9(1): 15-21.
42. Gottardi C J, Wong E, Gumbiner B M. E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. J Cell Biol, 2001, 153(5): 1049-1060.
43. Staal F J, Noort Mv M, Strous G J, Clevers H C. Wnt signals are transmitted through N-terminally dephosphorylated β-catenin. EMBO Rep, 2002, 3(1): 63-68.